ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesC82.25

C82.25

Billable

Follicular lymphoma grade III, unspecified, lymph nodes of inguinal region and lower limb

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 C82.25 is a billable code used to indicate a diagnosis of follicular lymphoma grade iii, unspecified, lymph nodes of inguinal region and lower limb.

Key Diagnostic Point:

Follicular lymphoma is a type of non-Hodgkin lymphoma characterized by the proliferation of follicle center (germinal center) B-cells. Grade III follicular lymphoma indicates a more aggressive form of the disease, with a higher proliferation index and a greater likelihood of transformation to a more aggressive lymphoma. This specific code, C82.25, refers to cases where the lymphoma is located in the lymph nodes of the inguinal region and lower limb. Patients may present with painless lymphadenopathy, and the disease can be associated with B-symptoms such as fever, night sweats, and weight loss. Diagnosis typically involves imaging studies, biopsy, and histological examination. Treatment options may include watchful waiting, chemotherapy, immunotherapy, or radiation therapy, depending on the stage of the disease and the patient's overall health. Accurate coding is essential for appropriate treatment planning and reimbursement.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiation between grades of follicular lymphoma
  • Specificity of lymph node involvement
  • Potential for transformation to aggressive lymphoma
  • Need for comprehensive staging information

Audit Risk Factors

  • Inadequate documentation of staging
  • Failure to note B-symptoms
  • Misclassification of lymphoma grade
  • Incomplete treatment documentation

Specialty Focus

Medical Specialties

Hematology/Oncology

Documentation Requirements

Detailed pathology reports, imaging studies, and treatment plans.

Common Clinical Scenarios

Diagnosis and management of newly diagnosed follicular lymphoma, treatment response evaluation.

Billing Considerations

Ensure accurate grading and staging are documented to support coding.

Pathology

Documentation Requirements

Comprehensive histological examination reports and grading criteria.

Common Clinical Scenarios

Biopsy interpretation and grading of lymphomas.

Billing Considerations

Clear documentation of the lymphoma subtype and grade is crucial for accurate coding.

Coding Guidelines

Inclusion Criteria

Use C82.25 When
  • Follow the official ICD
  • CM coding guidelines for neoplasms, ensuring accurate documentation of the lymphoma type, grade, and location
  • Include staging information and any associated symptoms

Exclusion Criteria

Do NOT use C82.25 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

96413CPT Code

Chemotherapy administration, intravenous

Clinical Scenario

Used for patients receiving chemotherapy for follicular lymphoma.

Documentation Requirements

Document the specific chemotherapy regimen and patient response.

Specialty Considerations

Oncology specialists must ensure accurate coding of chemotherapy administration.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of follicular lymphoma, improving the accuracy of diagnosis and treatment tracking. This specificity aids in better patient management and reimbursement processes.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of follicular lymphoma, improving the accuracy of diagnosis and treatment tracking. This specificity aids in better patient management and reimbursement processes.

Reimbursement & Billing Impact

reimbursement processes.

Resources

Clinical References

  • •
    National Comprehensive Cancer Network (NCCN) Guidelines

Coding & Billing References

  • •
    National Comprehensive Cancer Network (NCCN) Guidelines

Frequently Asked Questions

What is the significance of grading in follicular lymphoma?

Grading in follicular lymphoma indicates the aggressiveness of the disease, with higher grades (like grade III) associated with a greater likelihood of transformation to more aggressive forms and a need for more intensive treatment.